AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations

AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.

Previous post Peloton shares soar on digital content, apparel partnership with Lululemon
Next post : Shares of adhesives maker H.B. Fuller sink on warning of ‘slower than anticipated’ demand